For years, many women have faced a confusing message about menopause hormone therapy. It can be extremely effective for hot flashes and night sweats, yet older research created fears that the same treatment might harm the heart. A new U.S. study offers a more detailed picture. Researchers found that women with menopause symptoms who started […]

The post Menopause Hormone Therapy May Protect Heart Health appeared first on Knowridge Science Report.

For decades, one of the biggest problems in pain medicine has been surprisingly simple: the strongest medicines often come with the greatest risks. Opioids can make severe pain manageable, but they can also cause dependence, addiction, overdose and troublesome side effects. A new drug called LTG-001 is being developed to see whether powerful pain relief […]

The post A New Way to Stop Pain Without Opioids appeared first on Knowridge Science Report.

Losing weight is one challenge, but keeping it off while maintaining a healthy diet can be even harder. New research suggests that a Mediterranean-inspired eating plan redesigned for the American South can help adults maintain weight loss for two years while improving the nutritional quality of their diets. The program is called Med-South and was […]

The post Healthy Southern Diet Could Maintain Weight Loss appeared first on Knowridge Science Report.

A person being treated for heart disease may also have a hidden problem in the kidneys. New European guidelines say doctors should look for that connection much earlier, because damage to the heart and kidneys can feed into each other and increase the risk of serious illness. The European Society of Cardiology developed the new […]

The post Why Heart Patients May Need Their Kidneys Checked Too appeared first on Knowridge Science Report.

Fatty liver disease is extremely common, and many people have it without knowing. For years, it was often treated as a problem mainly involving the liver, especially when patients had no obvious symptoms. A new scientific review argues that this view may be too narrow. Researchers led by the University of Manchester and Northern Care […]

The post Symptomless Liver Problem Linked to Heart and Kidney Disease appeared first on Knowridge Science Report.

Parkinson’s disease has long been a diagnosis of observation and inference. Doctors watched for tremor, rigidity, and slowness of movement, and only at autopsy could the telltale clumps of alpha-synuclein protein—the pathological signature of the disease—be confirmed inside the brain. That diagnostic fog may finally be lifting. A new five-year study drawing on the landmark Parkinson’s Progression Markers Initiative (PPMI) has followed patients whose disease was defined not by their symptoms alone, but by biology: a positive cerebrospinal fluid seed amplification assay, the test that detects misfolded alpha-synuclein circulating in the nervous system. The results, published in Annals of Clinical and Translational Neurology, offer one of the clearest longitudinal pictures yet of how biologically confirmed Parkinson’s disease actually progresses in the era of modern treatment—and the findings are already reshaping how scientists think about staging, enrollment in clinical trials, and the very definition of the disease.

The research team set out with two central questions. First, what happens clinically to patients who test positive for synuclein seeding in their spinal fluid over five years of careful observation? Second, does a patient’s baseline stage on a new biological staging system—the Neuronal Synuclein Disease Integrated Staging System, or NSD-ISS—predict how quickly they will cross meaningful clinical milestones? Both questions cut to the heart of a quiet revolution in neurology. For more than a century, Parkinson’s was classified by what patients looked like in the examination room. Now, thanks to validated biomarkers, researchers can classify it by what is happening at the molecular level, potentially years before disabling symptoms emerge.

The seed amplification assay, or SAA, is the technological engine behind this shift. The test exploits a peculiar property of misfolded alpha-synuclein: it acts as a template that recruits normal, healthy synuclein proteins and forces them to misfold as well, seeding the aggregates known as Lewy bodies that riddle the brains of Parkinson’s patients. In the laboratory, a tiny sample of cerebrospinal fluid is mixed with synthetic alpha-synuclein and monitored for hours. If pathological seeds are present, the reaction accelerates into a detectable fluorescence signal. The assay has been validated across multiple international cohorts and, critically, against postmortem brain tissue, giving neurologists a window into pathology they previously could only glimpse after death. A complementary technique—detecting phosphorylated alpha-synuclein in small skin biopsies—has added a second, less invasive line of biological evidence.

Armed with these tools, two research groups have proposed frameworks for redefining Parkinson’s disease biologically. The SynNeurGe criteria classify patients by the combined presence of pathological alpha-synuclein biomarkers, neuroimaging evidence of neurodegeneration, and disease-relevant genetic variants. The Neuronal Synuclein Disease criteria take a parallel approach, defining disease by the presence of pathological synuclein as measured by a validated biomarker, with or without evidence of dopaminergic dysfunction detected through dopamine transporter imaging. The integrated staging system then arranges these biological anchors along a seven-stage ladder: Stage 0 reserved for carriers of fully penetrant mutations in the SNCA gene; Stages 1A and 1B for people with synuclein pathology but no symptoms, depending on whether dopaminergic dysfunction is present; Stages 2A and 2B for those with subtle signs that stop short of functional impairment; and Stages 3 through 6 capturing progressively severe clinical disability.

PPMI, the international observational study launched in 2010, provided the ideal laboratory for testing whether this staging framework means anything in the real world. The researchers focused on the sporadic Parkinson’s cohort: participants diagnosed within two years of enrollment who had never taken dopaminergic medication, whose examinations showed cardinal motor features, and whose dopamine transporter scans confirmed the characteristic deficit in the striatum. Crucially, the team selected only those participants who met biological NSD criteria through a positive CSF seed amplification assay, recruited before 2020 to guarantee at least five years of follow-up. This design deliberately stripped away a longstanding source of noise in Parkinson’s research: the clinical heterogeneity that arises when a “Parkinson’s” diagnosis might actually encompass unrelated neurodegenerative processes that mimic the disease but follow entirely different biological courses.

Over the five-year observation window, participants underwent an unusually thorough annual workup. Motor and non-motor function was tracked with the Movement Disorders Society Unified Parkinson’s Disease Rating Scale across all four of its parts, alongside the Hoehn and Yahr staging scale and the Schwab and England activities of daily living score. Smell was measured with the University of Pennsylvania Smell Identification Test, autonomic function with the SCOPA-AUT, mood with the Geriatric Depression Scale, and REM sleep behavior disorder risk with a dedicated screening questionnaire. Cognition was assessed with the Montreal Cognitive Assessment and, from the study’s third year onward, formal clinician diagnoses of normal cognition, mild cognitive impairment, or dementia. Medication burden was quantified as levodopa equivalent daily dose, and dopamine transporter imaging was repeated at years one, two, and four, quantified both in the putamen—the region most affected in Parkinson’s—and across the striatum as a whole.

The broad message from the five-year trajectories is one of measurable, biologically anchored progression. Patients recruited as freshly diagnosed, biologically confirmed sporadic Parkinson’s patients showed the expected decline across motor scales and dopaminergic imaging, with the earlier PPMI analysis by Simuni and colleagues having already documented significant—though modest—correlation between worsening clinical scores and falling DAT binding over five years. What the new analysis adds is the biological filter: by restricting the cohort to synuclein-seeding-positive individuals, the study reduces the contamination from look-alike conditions that has historically muddied progression estimates. When a cohort is defined by its underlying pathology rather than its outward symptoms, the resulting disease course becomes a truer reflection of what alpha-synuclein itself does to the nervous system over time.

Perhaps the most consequential findings concern prediction. If the NSD-ISS staging system is to earn its place in research clinics and, eventually, in therapeutic trials, it must do more than organize patients neatly on a page—it must forecast what comes next. The study analyzed whether a patient’s baseline stage predicted survival and the time required to reach clinically meaningful disease milestones: crossing thresholds on the clinical rating scales, advancing in Hoehn and Yahr stage, slipping in daily living independence, or developing cognitive impairment. The logic is straightforward and powerful. A patient sitting at Stage 2B—with confirmed synuclein pathology, dopaminergic dysfunction, and subtle signs but no functional impairment—should, in theory, march down the staging ladder at a predictable pace. Demonstrating that baseline stage genuinely stratifies risk would give trial designers a rational tool for enrichment, allowing them to recruit patients at the stage where a candidate drug is most likely to show benefit.

That trial-design implication is not academic. Across neurodegenerative disease research, therapeutic development is pivoting decisively toward biomarker-defined enrollment. The bitter lessons of Alzheimer’s trials—where anti-amyloid therapies only proved effective once trials recruited based on biological confirmation rather than syndrome alone—have not been lost on the Parkinson’s community. Drugs targeting alpha-synuclein directly, whether through immunotherapy, aggregation inhibition, or other mechanisms, are entering trials that increasingly require positive seed amplification assays or other biological confirmation as a gate for entry. A validated staging system that predicts five-year trajectory would allow sponsors to select participants early enough in the disease process for neuroprotective strategies to matter, while reserving later-stage patients for symptomatic interventions. The five-year PPMI data provide exactly the kind of naturalistic benchmark that such enrichment strategies demand.

The study also marks a conceptual milestone: the description of Parkinson’s disease under contemporary management. Patients diagnosed today are treated differently than those diagnosed twenty years ago, and their disease course may differ as a result. Describing outcomes in a biologically defined, prospectively observed cohort establishes a modern baseline against which future disease-modifying therapies can be judged. When an experimental drug claims to slow progression, the comparison will be against trajectories like those documented here—precise, biomarker-anchored, and free of the diagnostic uncertainty that plagued earlier natural history studies. In that sense, the paper functions simultaneously as a clinical report and as a foundation stone for the next generation of Parkinson’s trials.

What emerges from five years of watching synuclein-positive patients is a disease that can now be seen, staged, and tracked before it fully announces itself. The combination of CSF seed amplification assays, dopamine transporter imaging, and structured clinical assessment has converted a syndrome defined in the examination room into a biological disease measurable in the laboratory. If the staging system validated in this cohort continues to predict who declines fastest and who reaches milestones soonest, neurologists may one day tell a newly diagnosed patient not only what they have, but with unprecedented confidence what lies ahead—and researchers may finally test neuroprotective drugs in the early biological window where they stand the best chance of changing the story. For a disease that has resisted precise definition since James Parkinson first described it in 1817, that is a transformation worth watching.

Diabetes can slowly damage nerves throughout the body, leaving some people with pain, burning, tingling, or numbness that can become difficult to manage. Now, scientists at UTHealth Houston have developed an experimental treatment that slowed and even reversed this type of nerve damage in mice. The research was published in Science Translational Medicine. Although the […]

The post New Treatment Reverses Nerve Damage in Diabetes appeared first on Knowridge Science Report.

A mammogram does more than search for suspicious lumps. It can also show whether a woman’s breasts contain a large amount of dense tissue, a feature that has long been associated with a higher chance of developing breast cancer. For many years, breast density was especially important because it could hide small tumors on mammograms. […]

The post Dense Breasts May Create a Hidden Cancer-Friendly Environment appeared first on Knowridge Science Report.

Air pollution is often discussed as a long-term health threat, but new research suggests the body may begin responding after only a few hours. Scientists at the University of Louisville found that about three hours of exposure to polluted air was linked to a small but measurable change in the way the nervous system controls […]

The post Just 3 Hours of Dirty Air Could Harm Your Heart appeared first on Knowridge Science Report.

The company plans to triple the size of its data center fleet by 2032

Living with type 1 diabetes means making decisions about blood sugar every day. Even when people carefully count carbohydrates, use insulin correctly, and check their glucose regularly, their levels can still rise or fall unexpectedly. Researchers at Kaunas University of Technology, or KTU, are testing whether artificial intelligence could make these changes easier to anticipate. […]

The post AI Could Warn of Dangerous Blood Sugar Changes Before They Happen appeared first on Knowridge Science Report.

What does it actually cost to throw away the future? For a retired solar panel in the United States, the answer is surprisingly small, and that small number is deciding where the panel ends up.

The National Renewable Energy Laboratory (NREL) estimates it costs roughly $1 to $5 to landfill a silicon module and $15 to $45 to recycle one. Faced with that spread, most panel owners do the obvious thing. Fewer than 10% of decommissioned US panels are recycled.

That gap is worth naming, because it isn’t really about whether recycling is possible. It plainly is. The gap is about who pays, and when, and that turns out to be a very different kind of problem.

Why the cheap option keeps winning

A solar panel is not a mysterious object. Roughly 75% of a crystalline silicon panel by weight is glass, with an aluminum frame, a junction box, silicon cells, and small amounts of copper and silver threaded through it. The trouble is that the parts worth money are the parts hardest to get at, and the part that’s easy to handle, the glass, is worth almost nothing on its own.

So the economics run backwards from what you’d hope. NREL’s own behavioral modeling of US modules through 2050 found that, under baseline conditions, about 80% end up landfilled, 1% reused, and 10% recycled. Landfilling wins not because anyone prefers it, but because it’s the option that clears at the lowest price on the day the panel comes down.

Contrast that with the European Union, where producer-responsibility mandates fold the cost of end-of-life handling into the product from the start. Under those rules, recycling a panel has been put at about $0.75 per panel, and EU recycling rates reach 95%. Same physics, same materials, wildly different outcome. The variable is policy, not chemistry.

What actually costs money when you take a panel apart

Pulling the aluminum frame and the junction box off a panel is straightforward. The expensive step is what comes after: cleanly separating the glass from the silicon cells, then extracting the tiny quantities of silver and copper that sit inside. Those metals are where the recoverable value lives, and they are present in vanishingly small amounts. Silver sits at well under a tenth of a percent of a panel’s weight, yet it drives the recycling math.

Because clean separation is hard, many operations skip it. They shred the whole panel and sell the low-value glass cullet, capturing a fraction of what’s there. And the prize for doing the harder work isn’t large: an electrical engineer writing in The Conversation estimates the recoverable silver and copper in a single panel are worth only about $10 to $12, which is why recycling loses money under current processes. Layers glued together make the glass reclamation harder still.

The field’s own practitioners have been candid about the limits. As of 2022, Arizona State University’s Meng Tao, who works on PV recycling, told Chemical & Engineering News that “The recycling technologies we have today are still rudimentary.” That was an assessment of a young field, and the field has moved since. The same Conversation piece notes that advanced methods like salt etching can now recover over 99% of silver and 98% of silicon at high purity. The capability is arriving. Whether the economics arrive with it is the open question.

The Georgia plant’s bet

Which brings us to Cedartown. On January 29, 2026, SOLARCYCLE began commercial operations at a 255,000-square-foot plant that the company says recovers 96% of a panel’s material value and achieves 100% landfill diversion. According to CEO Suvi Sharma, the ” recycling facility in Cedartown represents a step-change in how we’re delivering end-of-life infrastructure.”

The more interesting move, to our eye, is what’s planned next door. SOLARCYCLE intends to feed the recovered glass into an adjacent solar-glass factory, with more than 80% of that plant’s planned 5 GW capacity already committed and first glass production slated for 2028. That vertical integration matters because it changes the value of the least-valuable material. If the glass has a buyer waiting rather than a landfill, the whole equation shifts. Sharma frames the ambition plainly: “The next phase of our growth is all about bringing solar recycling to industrial scale and delivering winning economics for our customers.” That’s a stated aim, not a demonstrated result, but it names the actual barrier: scale.

Not everyone is sold on the crush-and-separate approach. Terry Ko, chief operating officer of PV Circonomy, whose company markets a layer-by-layer alternative, has argued that “Once glass, silicon, metals, and polymers are reduced into mixed particles, contamination becomes a significant challenge regardless of the subsequent separation technology employed.” Ko has a commercial stake in that critique, and the trade coverage it appeared in noted the absence of industry-wide purity standards. Worth hearing, not yet settled.

The retirement wave that’s already loading

All of this would be an academic argument if the panels weren’t coming. They are.

NREL’s Garvin Heath put the timing plainly: “Installations two decades ago are nearing their end of life, and that becomes a challenge for the waste industry.” Roughly one million tons of US panel waste is expected by 2030, and NREL’s global assessment projects the volume of retired modules could reach up to 80 million metric tons by 2050. That’s a forecast, not a certainty, but the trend line under it is firm: US utility-scale solar is set to add 70 GW of new solar capacity across 2026 and 2027. Every panel installed is a panel that will one day retire.

There’s also a supply-chain angle that reframes the whole thing. Several of the metals inside panels appear on US critical-minerals lists and are largely imported. Recovered silver, copper, and silicon are not just waste avoided; they’re domestic material that didn’t have to be dug up or shipped in. Heath’s argument is that the lead time here is long, so the work has to start early: “Because it takes a long time to develop technology and policy and solutions to dealing with end-of-life products, this is something we need to start to address today.”

Incentive, not inevitability

The technology to recover most of a panel exists, salt etching hits high-purity numbers, and a plant in Georgia is now claiming near-total value recovery. What keeps most panels in the ground is that landfilling is cheap on the day the decision gets made, and the cost of recycling lands on whoever is holding the panel at end of life rather than on whoever profited from it at the start.

The EU’s $0.75-per-panel figure is the tell. When the cost is built in early and the value chain is closed, the same object that looks like expensive waste in one system looks like feedstock in another. Cedartown’s bet on selling its recovered glass next door is a private-sector version of the same logic: make the low-value material worth something, and the math stops fighting you.

The $1-to-$5 number isn’t telling us that recycling is too hard. It’s telling us who currently pays for the easy way out. Change that, through mandates, through scale, or through a buyer waiting on the other side of the shredder, and the cheap option stops being the only rational one.

The post Dropping a dead solar panel into a U.S. landfill costs $1 to $5, while recycling the same panel has been estimated at $15 to $45. That gap helps explain why most go into the ground, even though a plant that opened in Georgia this year says it recovers 96 percent of a panel’s material value. appeared first on Space Daily.

A study has found a possible link between vitamin B12 and inflammation in the body. People with higher levels of vitamin B12 in their blood tended to have lower levels of two important signs of inflammation. The research was published in the Journal of the Science of Food and Agriculture. The findings add to growing […]

The post Vitamin B12 May Help Keep Inflammation in Check appeared first on Knowridge Science Report.

A medical report published earlier this week says a boy in the U.K. developed erythema ab igne, or "toasted skin syndrome," after resting a laptop on his abdomen for up to eight hours a day, often while it was charging. "The marks were described as being in a patch about 15 centimeters (six inches) wide, made of flat, reddish-brown 'interlacing lines forming irregular circles and a lace-like morphology,'" reports Ars Technica. From the report: Based on the appearance, the doctors started reconsidering some sort of bruising and started asking him more questions. This is when he mentioned that he was homeschooled and used a laptop for his schoolwork. He said he typically did his work by resting his laptop on his abdomen while he worked, sometimes for up to eight hours a day, and often while the laptop was charging. Then they understood what it was. The doctors diagnosed the boy with erythema ab igne (EAI), which translates from Latin as "redness from fire" and is also sometimes called "toasted skin syndrome." This is a skin condition caused by repeated, prolonged exposure to low-grade heat -- heat not hot enough to cause actual burns. It's most often seen in adults, and common causes include using heating pads or hot water bottles for chronic pain or sitting too close to space heaters. Some people also develop it from certain occupational hazards, like glassblowing and metal work. EAI produces a lace-like rash, just like the boy's. It's unclear how EAI develops exactly. But researchers hypothesize that chronic heat exposure leads to damage to superficial blood vessels and the release of red blood cells, forming the tell-tale red reticulated pattern. While the boy's condition looked ominous, the good news is that EAI is generally benign and reversible -- once you remove the heat source. For severe or long-term conditions, some pigmentation and scarring can remain. But the boy's parents checked back in over several months, reporting that the rash faded and then completely resolved. Hopefully, he also got some sort of laptop stand.

Read more of this story at Slashdot.

When a tunnel catches fire, temperatures inside the concrete lining can soar to 800 or 900 degrees Celsius, and the emergency response almost always involves dousing the structure with water. A new study suggests that this familiar firefighting image—flames followed by a torrent of cooling water—may be doing far more damage to the concrete than engineers have typically accounted for. Researchers investigating basalt fiber-reinforced concrete have found that how a fire-damaged structure is cooled can be as important as how hot it got in the first place, with water quenching consistently inflicting greater strength loss than slow, natural cooling across every temperature they tested.

The research, published in Case Studies in Construction Materials, systematically examined how heating temperature, cooling regime, fiber content, and impact loading combine to determine whether concrete survives a fire with its load-bearing capacity intact. The team, led by Yang Liu and colleagues including Delin Li, Jinyue Dong, Yingda Zhang, Xianliang Zhou, and Qiong Zhou, chose basalt fiber-reinforced concrete, or BFRC, as their test material because of the fiber’s unusual combination of properties. Basalt fibers, drawn from volcanic rock, offer high tensile strength, thermal stability up to melting points between 1350 and 1450 degrees Celsius, and a cost profile far more attractive than premium alternatives such as carbon fiber. This makes them an appealing candidate for tunnel linings, where fire resistance and economy must be balanced.

The experimental design was exhaustive. The researchers prepared a C35-grade concrete mix—the grade commonly recommended for tunnel design—using ordinary Portland cement, medium sand, and continuously graded gravel between 5 and 10 millimeters. Into this base mix they incorporated chopped basalt fibers, 12 millimeters long with a monofilament diameter of 17 micrometers, at volume fractions of 0, 0.1, and 0.2 percent. The fibers were added in small batches during dry mixing to prevent agglomeration, and the fresh concrete was cast into cylindrical specimens measuring 50 millimeters in diameter and 25 millimeters in height, then cured under standard conditions at 20 degrees Celsius and 95 percent relative humidity.

The thermal assault began in a high-temperature electric oven capable of reaching 1200 degrees Celsius. Specimens were heated at a controlled rate of 5 degrees Celsius per minute to target temperatures of 200, 400, 600, and 800 degrees Celsius, then held at temperature for a full hour to ensure the heat penetrated the interior. Half the specimens were then removed and allowed to cool naturally in ambient air, mimicking a structure left to cool on its own after a fire. The other half were plunged immediately into a tank of tap water, replicating the thermal shock of firefighting operations. After cooling, the water-immersed specimens were conditioned in air for seven days to return them to a natural moisture state before testing.

The dynamic mechanical properties were then probed using a split Hopkinson pressure bar, the workhorse instrument for measuring how materials behave under the extreme strain rates produced by impacts and blasts. The apparatus used bars 75 millimeters in diameter, made of high-strength steel with an elastic modulus of 210 gigapascals, with a striker bar propelled by compressed gas striking an incident bar that transmitted stress waves through the specimen. Three impact velocities—3.5, 4.4, and 5.2 meters per second—were tested, achieved by varying the operating gas pressure, with three specimens per condition. A thin pulse shaper was pasted at the impact end of the incident bar to smooth out high-frequency oscillations, and stress equilibrium between the two faces of each specimen was verified from strain-gauge signals, confirming the reliability of the data. Fragments from each impact were sieved through meshes ranging from 4.75 millimeters down to 75 micrometers so that a fractal dimension could be calculated, providing a quantitative measure of how thoroughly each specimen shattered.

The visual evidence of thermal damage followed a familiar but telling progression. At 200 degrees Celsius, the concrete surfaces turned bluish-gray, with no cracking. By 400 degrees, the color shifted to yellowish-gray, still structurally sound. At 600 degrees, fine cracks appeared along with slight surface peeling, and by 800 degrees the specimens showed severe cracking, spalling, and edge breakage. Water-cooled specimens generally exhibited more pronounced surface damage than their naturally cooled counterparts, and at 800 degrees the concave shape at the start of the stress-strain curve—evidence of pre-existing microcracks being closed under compression—was especially marked in the water-quenched samples.

The strength data told a stark quantitative story. For naturally cooled specimens containing 0.2 percent basalt fiber, the dynamic peak stress at an impact velocity of 3.5 meters per second fell from 51.1 megapascals at room temperature to 18.6 megapascals at 800 degrees—a reduction of 63.6 percent. Water cooling made matters worse across the board: at the same impact velocity, the reductions reached 23.9 percent at just 200 degrees and climbed to 64.9 percent at 800 degrees. Averaged across the temperature range, each 100-degree increment cost naturally cooled specimens roughly 6.7 to 8.0 percent of their strength, while water-cooled specimens lost about 7.5 to 8.1 percent per 100 degrees. The gap between the two cooling regimes widened at higher impact velocities: at 5.2 meters per second and 800 degrees, the water-cooled specimens suffered 6.4 percent greater strength loss than the naturally cooled ones, whereas at the lowest velocity the difference was a mere 1.3 percent. The explanation lies in competing timescales—at slow loading rates, cracks have time to propagate and dissipate energy, blunting the effect of water-induced damage, but at high rates the loading outpaces the material’s energy dissipation, and the microcracks created by thermal shock propagate catastrophically.

Against this backdrop of degradation, the basalt fibers demonstrated genuine protective power. At every temperature from 200 to 800 degrees, specimens with 0.2 percent fiber content outperformed both plain concrete and the 0.1 percent mix. At 400 degrees and an impact velocity of 3.5 meters per second, the naturally cooled fiber-reinforced specimens reached peak stresses of 40.1 megapascals, some 16.9 percent above plain concrete, while at 200 degrees under water cooling the 0.2 percent mix achieved 38.8 megapascals—a remarkable 32.4 percent improvement over unreinforced concrete. The mechanism, the authors explain, is architectural: randomly distributed fibers form a three-dimensional network that binds tightly with the cementitious matrix, reduces internal pores and cracks, and bridges microcracks before they can coalesce into fracture surfaces. But this protection has a ceiling. Above roughly 600 degrees, the fibers begin to degrade and lose their reinforcing capability, and the fiber-matrix interface—already weakened by thermal mismatch between fiber and paste—becomes a liability during water quenching.

Fractal analysis of the impact debris added another layer of insight. The fractal dimension of the fragments rose steadily with temperature, from around 1.82 at 200 degrees to above 2.3 at 800 degrees under the highest loading rate, indicating progressively finer and more complex fragmentation. Water-cooled specimens consistently shattered into finer pieces than naturally cooled ones, particularly at 600 and 800 degrees, confirming that the steep thermal gradients during quenching seed dense populations of microcracks that later explode into fracture networks under impact.

Microstructural investigation grounded these observations in chemistry and physics. X-ray diffraction of specimens heated to 800 degrees showed the disappearance of calcium hydroxide peaks and weakened calcium carbonate signals, evidence that these phases had thermally decomposed—reactions that release vapor, increase porosity, and weaken the matrix. Scanning electron microscopy revealed the deterioration in vivid detail: an unheated specimen showed a dense microstructure with abundant calcium-silicate-hydrate gel and a compact interfacial transition zone around each aggregate, while specimens heated to 800 degrees contained no detectable C-S-H gel at all, their structure riddled with pores and cracks and hosting instead a dicalcium silicate-like phase. Comparing cooling regimes at 400 degrees, the naturally cooled sample remained relatively dense and rich in hydration products, whereas its water-quenched twin displayed obvious cracks at the interfacial transition zone and a loosened surrounding matrix—the fingerprint of thermal shock stress racing through the cooling material.

The practical implications reach well beyond the laboratory. Tunnel linings that survive a fire are routinely assessed and, if necessary, repaired, but this study shows that the assessment itself must account for the cooling history. A lining quenched by firefighting water may be significantly weaker than its peak temperature alone would suggest, particularly if it subsequently faces dynamic loads from traffic vibration, rockfall impacts, or secondary events. Conversely, the results give engineers a positive tool: specifying basalt fiber reinforcement at around 0.2 percent by volume can meaningfully bolster the impact resistance of fire-exposed concrete below 600 degrees, at a modest material cost. The authors frame their work as a theoretical foundation for post-fire safety assessment of tunnel linings and for the wider engineering adoption of basalt fiber-reinforced concrete—a reminder that in structural fire engineering, what happens in the minutes after the flames matter almost as much as the fire itself.

Publier un portfolio professionnel ou une page dédiée à un projet personnel ne devrait pas transformer la soirée en séance de bricolage technique. C'est justement l'angle choisi par IONOS avec sa formule Plus : une base web pensée pour ceux qui dépassent le simple site vitrine, sans pour autant...

How do you search for the world’s smallest monkey? Earlier this year, Nicolás Schuldt Durán took on this task after he was approached by members of an Indigenous community in Ecuador. Ever since, he’s been tapping into the knowledge of the Siekopai people and combining it with passive acoustic monitoring technology to look for pygmy marmosets. Spoiler alert: They’re still looking for this elusive species. Working in the Siekoya Remolino community in Ecuador, Durán is collaborating with Indigenous community members to track pygmy marmosets (Cebuella pygmaea), locally called leoncillo, and gather data on where they live and how they’re faring. “The community has already been setting up camera traps and running a territorial monitoring program to catch hunters and loggers,” Durán, founder of conservation technology organization Neblina Labs, told Mongabay in a video interview. “This is just adding one more tool to their toolkit to monitor biodiversity.” Pygmy marmosets are threatened by the illegal pet trade as well as deforestation in the Amazon Rainforest. Image by David Reece via Flickr (CC BY-SA 2.0). Pygmy marmosets, native to the western Amazon Basin, are so small that an adult weighs only 140-150 grams (about 5 ounces), or the weight of a small apple. They live high up in trees and are known for their high-pitched calls, including whistles that are often in the ultrasonic range and which they use to communicate with one another. Classified as vulnerable to extinction, these primates are threatened by the illegal pet trade as well as deforestation…This article was originally published on Mongabay

Scientists have unveiled a computational design for a terahertz metasurface biosensor that combines five distinct materials—graphene, MXene, tungsten disulfide, gold, and copper—into a single multilayer architecture capable of detecting refractive-index changes associated with chikungunya virus infection. The study, published in Results in Optics by G. Arunachalam, A.R. Kalaiarasi, Giri.G. Hallur, and V. Parthasarathy, reports a numerically predicted sensitivity of 907 GHz per refractive-index unit, among the highest values reported for hybrid-material terahertz biosensors, and couples the electromagnetic design to an XGBoost machine-learning surrogate model that predicts sensor behavior with accuracies exceeding 99.8 percent.

Chikungunya virus is an enveloped, positive-sense single-stranded RNA alphavirus transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes. While mortality remains low, generally below 0.1 percent, the broader public health burden arises from severe polyarthralgia that can persist for months or even years in a substantial fraction of patients across tropical and subtropical regions. With no approved antiviral therapy or licensed vaccine currently available, diagnostic accuracy sits at the center of clinical management and transmission control. Yet existing diagnostic tools face significant practical constraints, particularly in point-of-care and field settings.

Serological methods such as enzyme-linked immunosorbent assay suffer from cross-reactivity with related alphaviruses, including Ross River and O’nyong-nyong viruses, reducing diagnostic specificity. Real-time reverse transcription polymerase chain reaction offers high sensitivity during the acute phase but depends on laboratory infrastructure, trained personnel, and controlled sample handling. Virus isolation in cell culture provides confirmatory results but requires biosafety level-3 facilities and extended processing time. These limitations have motivated the search for rapid, label-free sensing approaches capable of operating at clinically relevant concentrations in decentralized environments.

The new work turns to the terahertz band, spanning roughly 0.1 to 10 THz, which lies between microwave and infrared regions of the electromagnetic spectrum. Terahertz radiation is non-ionising, with photon energies in the millielectronvolt range, allowing interaction with biological samples without causing ionising damage. Crucially, terahertz waves couple to low-frequency vibrational and rotational modes of biomolecules such as proteins, nucleic acids, and polysaccharides, producing measurable spectral features that support label-free detection. Because biological media including blood plasma and viral suspensions exhibit refractive-index variations in this domain, differences on the order of 0.01 to 0.02 refractive-index units can shift resonance frequency and field distribution when coupled to resonant sensing structures.

The proposed sensor is built around a periodically repeated square unit cell containing two identical square resonators, 2000 nanometers on a side, coated with tungsten disulfide—a two-dimensional transition metal dichalcogenide with strong light–matter interaction, high carrier mobility, and excellent dielectric confinement. This layer localizes the electric field in the sensing region and increases the interaction volume between the resonant field and the surrounding analyte. A pair of concentric circular rings, 3200 and 3800 nanometers in diameter and functionalized with MXene, surrounds the resonators, enhancing electromagnetic coupling, promoting efficient charge transport, and strengthening plasmonic interactions between resonator elements. An outer gold ring, 6000 nanometers in diameter, serves as the main plasmonic resonator supporting strong localized surface plasmon resonances with low optical loss. The entire multi-resonant assembly is embedded within a monolayer graphene sheet measuring 14,000 by 14,000 nanometers, which acts as a broadband absorber and a high-mobility charge transport medium whose electrically tunable chemical potential allows dynamic, active control of the resonance characteristics. Copper elements woven into the architecture provide supplementary conductive pathways that reinforce current distribution and coupling among the hybrid resonators. The structure rests on a silicon dioxide substrate, chosen for its low dielectric loss and mechanical robustness, which preserves the resonance quality factor.

The authors stress that the multilayer design is compatible with established microfabrication techniques. Fabrication would begin with a cleaned silicon dioxide substrate, followed by polymer-assisted transfer of monolayer graphene and thermal annealing. Gold and copper resonators can be deposited through electron-beam evaporation or magnetron sputtering with lift-off patterning, MXene rings through solution-based deposition, and the tungsten disulfide layer through chemical vapor deposition or thin-film transfer. With a unit-cell dimension of approximately 14 micrometers, the required feature sizes fall comfortably within conventional photolithography capabilities, and because fabrication imperfections remain far smaller than the operating terahertz wavelength, moderate tolerances are expected to have only limited influence on the electromagnetic response. For biosensing, the graphene surface could subsequently be functionalized with chikungunya-specific antibodies or aptamers using EDC/NHS or pyrene-based linker chemistries.

The electromagnetic modeling, performed in COMSOL Multiphysics, reveals a pronounced resonance at 0.355 THz, where electric-field simulations show the strongest and most spatially extensive enhancement. Varying the graphene chemical potential from 0.1 to 0.9 electronvolts produced dramatic modulation of the transmission contrast, which increased roughly 36-fold at the highest bias, from less than one percentage point to more than 27 percentage points, while peak transmission remained essentially unchanged above 98.6 percent. This asymmetric response—stable maxima paired with strongly modulated minima—arises because increasing chemical potential enhances graphene’s intraband conductivity, deepening resonant absorption through stronger light–matter interaction. The sensor also demonstrated remarkable angular robustness, maintaining peak transmittance above 97.8 percent across incident angles from 0 to 80 degrees, an important tolerance for realistic deployment where normal incidence cannot always be guaranteed.

Geometric optimization identified an outer circular resonator radius of 2500 nanometers and a square resonator side length of 2500 nanometers as the dimensions that maximize resonance strength, driving minimum transmittance down to approximately 65 to 67 percent and signifying optimal electromagnetic confinement within the active sensing region. When evaluated across refractive indices from 1.33 to 1.39, a range encompassing reported values for healthy plasma (approximately 1.35 RIU), healthy platelets (1.39 RIU), chikungunya-infected plasma (1.33 RIU), and infected platelets (1.38 RIU), the optimized configuration achieved a maximum sensitivity of 907 GHz/RIU, a figure of merit of 18.519 RIU⁻¹, a minimum detection limit of 0.061 RIU, a sensor resolution of 55.178, and a refractive-index resolution of 0.001 RIU. In comparative benchmarks against recently reported graphene- and hybrid-material-based terahertz biosensors—including graphene/copper/aluminum, graphene/silicon dioxide, MXene–graphene–black phosphorus, and graphene-integrated copper–silver designs—the proposed architecture’s sensitivity exceeded most published values, reflecting the synergistic field confinement produced by the five-material stack.

The machine-learning component addresses one of the central bottlenecks in metasurface development: the computational cost of repeated full-wave finite-element simulations during structural optimization. The team trained an XGBoost regressor, an ensemble method based on gradient-boosted decision trees, on simulation data covering incidence-angle variation and circular-ring dimension variation, using stratified sampling with 80 percent of data for training and 20 percent held out for independent testing, alongside five-fold cross-validation and grid-search hyperparameter optimization. The model captured more than 99.7 percent of response variance on unseen data, with mean absolute percentage errors below 0.162 percent and prediction accuracies from 99.838 to 99.959 percent. Acting as a computational surrogate, the trained model enables rapid interpolation across the design space without sacrificing the fidelity of the underlying electromagnetic model.

The authors are careful to frame the work as a computational proof-of-concept rather than an experimentally validated diagnostic. The sensor detects changes in the local dielectric environment surrounding the resonators, not viral particles or nucleic acids directly, and refractive-index sensing alone cannot intrinsically distinguish chikungunya from other viruses with similar dielectric properties. Analytical specificity in practice will depend on surface biofunctionalization with chikungunya-specific recognition molecules immobilized on the graphene or gold sensing surface. Future work will focus on device fabrication, biofunctionalization, calibration with reference refractive-index standards, experimental validation with clinically relevant plasma and platelet samples, and systematic evaluation of selectivity against related arboviruses—steps that would transform this numerically validated platform into a practical tool for rapid, label-free infectious disease diagnostics in the field.

Anthropic PBC uncovered a group in northern Yemen — where Iran-backed Houthi militants operate — using its Claude AI model to support the development of missile and rocket systems, highlighting growing concerns over the use of advanced AI in military programs and by non-state actors.

La escena viral enciende el miedo: ¿podría una ballena tragarse a una persona? Descubre por qué la clave está en su garganta.